Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Delivra Health Brands Inc

Healthcare US DHBUF

0.0781USD
0.0022(2.90%)

Last update at 2026-06-22T16:35:00Z

Day Range

0.080.08
LowHigh

52 Week Range

0.060.26
LowHigh

Fundamentals

  • Previous Close 0.08
  • Market Cap4.82M
  • Volume5000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.38M
  • Revenue TTM13.09M
  • Revenue Per Share TTM0.42
  • Gross Profit TTM 6.36M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Income before tax 0.88M -0.18400M -7.00900M -22.67200M -62.77100M
Minority interest - - - 0.00000M 1.54M
Net income 0.88M -0.18400M -7.00900M -28.53800M -79.85700M
Selling general administrative 5.80M 4.86M 6.50M 8.89M 16.42M
Selling and marketing expenses - - - - -
Gross profit 6.40M 4.82M 2.60M 1.92M -0.63100M
Reconciled depreciation 1.31M 1.33M 2.12M 2.66M 3.07M
Ebit - -1.36300M -6.01200M -9.26000M -14.10900M
Ebitda - - -4.25500M -6.60200M -58.89400M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.71000M -1.36300M -6.01200M -9.26000M -19.72200M
Other operating expenses - - - - -
Interest expense 0.17M 0.25M 0.64M - 0.80M
Tax provision - - - - -
Interest income - - - 0.04M -
Net interest income -0.16900M -0.25000M -0.63500M 0.04M -0.80400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 12.38M 9.79M 8.14M 7.96M 8.38M
Total operating expenses 13.09M 11.15M 14.15M 17.22M 28.11M
Cost of revenue 5.98M 4.97M 5.54M 6.04M 9.02M
Total other income expense net 1.75M 1.43M -0.36200M -13.45300M -42.24500M
Discontinued operations - - - -5.86600M -22.65800M
Net income from continuing ops 0.88M -0.18400M -7.00900M -22.67200M -62.77100M
Net income applicable to common shares - -0.18400M -7.00900M -28.53800M -79.85700M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 10.05M 10.56M 11.59M 19.06M 57.84M
Intangible assets 1.19M 2.47M 3.67M 6.03M 12.63M
Earning assets - - - - -
Other current assets - - 2.34M - 15.05M
Total liab 4.86M 7.17M 8.21M 9.09M 21.27M
Total stockholder equity 5.19M 3.39M 3.37M 9.98M 33.52M
Deferred long term liab - - - - -
Other current liab - 0.72M 0.59M 0.54M 1.61M
Common stock - 148.23M 148.23M 148.23M 146.20M
Capital stock 148.63M 148.23M 148.23M 148.23M 146.20M
Retained earnings -169.16200M -170.03800M -169.85400M -162.84500M -134.30700M
Other liab - - - - -
Good will - - - - 0.00000M
Other assets - - 0.15M 0.29M 0.40M
Cash 4.20M 2.72M 1.08M 4.43M 1.41M
Cash and equivalents - - - - -
Total current liabilities 3.07M 5.47M 6.54M 7.24M 19.19M
Current deferred revenue - - - - -
Net debt - - 1.02M - 4.57M
Short term debt - - - - -
Short long term debt 0.24M 0.25M 0.44M 0.31M 3.89M
Short long term debt total - - - - -
Other stockholder equity - 25.20M 25.00M 24.60M 21.62M
Property plant equipment - 0.18M 0.27M 2.91M 16.39M
Total current assets 8.76M 7.92M 7.49M 9.84M 28.41M
Long term investments - - - - 0.00000M
Net tangible assets - 0.92M -0.30200M 3.94M 20.88M
Short term investments 0.00000M 0.01M 0.03M 0.71M -
Net receivables 2.69M 2.74M 1.71M 2.14M 1.77M
Long term debt 1.78M 1.70M 1.67M 1.85M 2.08M
Inventory 1.48M 2.26M 2.22M 2.28M 9.29M
Accounts payable 0.71M 2.19M 3.58M 4.87M 10.74M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 1.29M 2.65M 4.10M 9.23M 29.43M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Investments 0.01M 2.91M 1.27M 1.03M 1.26M
Change to liabilities - 0.04M -0.69000M -6.03800M -0.02500M
Total cashflows from investing activities - 2.91M 1.35M 12.27M -3.63600M
Net borrowings -0.22500M -0.25500M -0.30900M -4.08200M 3.17M
Total cash from financing activities 0.59M -0.25500M -0.30900M 0.45M 3.17M
Change to operating activities - -0.07800M 0.33M 0.40M 0.50M
Net income 0.88M -0.18400M -7.00900M -28.53800M -79.85700M
Change in cash 1.48M 1.64M -3.34700M 3.02M -18.89500M
Begin period cash flow 2.72M 1.08M 4.43M 1.41M 20.30M
End period cash flow 4.20M 2.72M 1.08M 4.43M 1.41M
Total cash from operating activities 0.76M -1.08800M -4.44100M -9.64700M -18.35900M
Issuance of capital stock 0.82M - 0.00000M 4.49M -
Depreciation 1.31M 1.29M 2.08M 2.22M 2.70M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.52M -0.46700M -0.71700M 2.27M -6.36500M
Change to account receivables - -0.86700M -0.22700M 1.12M 2.02M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome - -0.85800M 1.76M 18.92M 62.66M
Capital expenditures 0.00000M 0.04M 0.01000M 0.03M 6.29M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.19800M -1.37600M -1.30700M -2.24600M -3.86700M
Stock based compensation 0.03M 0.15M 0.35M 0.58M 2.02M
Other non cash items 0.28M 0.07M 0.25M 0.96M 1.63M
Free cash flow 0.76M -1.12900M -4.46300M -9.68000M -24.67400M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DHBUF
Delivra Health Brands Inc		 0.0022 2.90% 0.08 - 3.62 0.37 1.48 0.26 10.08
ZTS
Zoetis Inc		 -2.82 3.58% 75.89 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.19 0.62% 30.56 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 157.12 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 - -% 42.94 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Delivra Health Brands Inc., through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide. It offers liquid sleep shots, gummies, and sleep powder packets, as well as pain relief creams under the Dream Water, LivRelief, and Dream Water brands. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.

Delivra Health Brands Inc

999 Canada Place, Vancouver, BC, Canada, V6C 3E2

Key Executives

Name Title Year Born
Mr. Frank A. Holler MBA Independent Exec. Chairman 1957
Mr. Gord Davey Pres, CEO & Director NA
Mr. Jack Z. Tasse C.M.A., CPA CFO & Corp. Sec. NA
Mr. Matthew Wagar Sr. VP of Marketing & Innovation NA
Ms. Ann Gallery Sr. VP of Corp. Communications NA
Mr. Will Stewart Sr. VP of Corp. & Public Affairs 1976
Mr. Christopher Podolsky CA, CPA Advisor NA
Mr. Jonathan David Hartshorn Pres & CEO of Satipharm 1970
Mr. Kwong Choo CGA, CPA VP of Fin. 1964
Mr. Frank A. Holler MBA Independent Executive Chairman 1957

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.